Evaluation of commercial rapid lateral flow tests, alone or in combination, for SARS-CoV-2 antibody testing

Authors

Peter U Fischer, Washington University School of Medicine in St. Louis
Kerstin Fischer, Washington University School of Medicine in St. Louis
Kurt C Curtis, Washington University School of Medicine in St. Louis
Yuefang Huang, Washington University School of Medicine in St. Louis
Nicole Fetcho, Washington University School of Medicine in St. Louis
Charles W Goss, Washington University School of Medicine in St. Louis
Gary J Weil, Washington University School of Medicine in St. Louis

Journal

The American Journal of Tropical Medicine and Hygiene

Publication Date

2021

Volume

105

Issue

2

First Page

378

Last Page

386

Document Type

Open Access Publication

DOI

10.4269/ajtmh.20-1390

Rights and Permissions

Fischer PU, Fischer K, Curtis KC, et al. Evaluation of Commercial Rapid Lateral Flow Tests, Alone or in Combination, for SARS-CoV-2 Antibody Testing [published online ahead of print, 2021 Jun 28]. Am J Trop Med Hyg. 2021;tpmd201390. doi:10.4269/ajtmh.20-1390

Recommended Citation

Fischer, Peter U; Fischer, Kerstin; Curtis, Kurt C; Huang, Yuefang; Fetcho, Nicole; Goss, Charles W; and Weil, Gary J, "Evaluation of commercial rapid lateral flow tests, alone or in combination, for SARS-CoV-2 antibody testing." The American Journal of Tropical Medicine and Hygiene. 105, 2. 378 - 386. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10733